Growth Metrics

Protalix BioTherapeutics (PLX) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 48.71%
Dec 31, 2025 11.62%
Sep 30, 2025 63.11%
Jun 30, 2025 74.60%
Mar 31, 2025 51.78%
Dec 31, 2024 28.72%
Sep 30, 2024 -15.19%
Jun 30, 2024 -26.72%
Mar 31, 2024 2,854.96%
Dec 31, 2023 415.50%
Sep 30, 2023 432.18%
Jun 30, 2023 494.39%
Mar 31, 2023 113.47%
Dec 31, 2022 -76.28%
Sep 30, 2022 -5,505.63%
Jun 30, 2022 -357.46%
Mar 31, 2022 -151.61%
Dec 31, 2021 77.68%
Sep 30, 2021 100.64%
Jun 30, 2021 111.05%
Mar 31, 2021 146.97%
Dec 31, 2020 61.55%
Sep 30, 2020 52.98%
Jun 30, 2020 48.49%
Mar 31, 2020 48.41%
Dec 31, 2019 -32.98%
Sep 30, 2019 -47.78%
Jun 30, 2019 -57.89%
Mar 31, 2019 -68.88%
Dec 31, 2018 -79.52%
Sep 30, 2018 -83.89%
Jun 30, 2018 -106.80%
Mar 31, 2018 48.24%
Dec 31, 2017 -195.84%
Sep 30, 2017 -72.62%
Jun 30, 2017 -159.13%
Mar 31, 2017 -2,683.77%
Dec 31, 2016 -191.58%
Sep 30, 2016 77.96%
Jun 30, 2016 87.76%
Mar 31, 2016 104.33%
Dec 31, 2015 119.56%
Mar 31, 2015 -82.13%
Dec 31, 2014 -106.34%
Mar 31, 2014 -434.43%
Dec 31, 2013 -702.68%
Sep 30, 2013 -450.08%
Jun 30, 2013 -252.44%
Mar 31, 2013 2.69%
Dec 31, 2012 87.13%
Sep 30, 2012 127.50%
Jun 30, 2012 190.35%
Mar 31, 2012 -237.24%
Dec 31, 2011 -130.30%
Sep 30, 2011 -390.06%
Jun 30, 2011 -460.04%